Related by context. All words. (Click for frequent words.) 74 Aplidin 74 romidepsin 74 histone deacetylase inhibitor 73 YONDELIS 73 Factor VIIa 73 selective inhibition 73 radiation sensitizer 73 somatostatin analogue 72 novel peptide 72 Xanafide 72 targeted antifolate 72 FK# 72 Degarelix 72 Proxinium TM 72 pan HDAC inhibitor 72 preclinically 72 ENMD # 72 targeting CD# 71 CBLC# 71 CEQ# 71 HSP# inhibitor 71 indibulin 71 investigational humanized monoclonal antibody 71 sorafenib Nexavar 71 proteasome inhibitor 71 thalidomide Thalomid 71 IMA# 71 PXD# 71 Amrubicin 71 Onconase 71 MGd 71 HQK 71 Aplidin R 71 vorinostat 70 fosbretabulin 70 Romidepsin 70 IL# PE#QQR 70 bevacizumab Avastin ® 70 vinca alkaloid 70 OMP #M# 70 pain palliation 70 mertansine 70 histone deacetylase HDAC inhibitor 70 HuMax EGFr 70 angiogenesis inhibitor 70 PSMA ADC 70 Tyrima 70 Carfilzomib 70 antibody MAb 70 anticancer agent 70 GRNVAC1 70 Cloretazine 70 inhibitor RG# 70 AEG# 70 cetuximab Erbitux R 70 Kahalalide F 70 INCB# [001] 70 bortezomib Velcade 70 Yondelis ® 70 Pertuzumab 70 Dasatinib 70 HER2 positive metastatic breast 70 Pemetrexed 70 novel histone deacetylase 70 Omacetaxine 70 preclinical efficacy 69 Phase Ib II 69 Vidofludimus 69 targeted radiotherapeutic 69 Sym# 69 receptor tyrosine kinase inhibitor 69 orally bioavailable 69 ON #.Na 69 Gleevec resistant 69 PKC# 69 tumorigenicity 69 mTOR mammalian target 69 xenograft models 69 Cloretazine ® 69 Panzem R NCD 69 Phase #b/#a clinical 69 Seliciclib 69 YONDELIS R 69 mitogen activated ERK kinase 69 Azedra 69 gefitinib Iressa 69 Vidaza azacitidine 69 erlotinib Tarceva ® 69 anti leukemic 69 humanized anti 69 Squalamine 69 oral prodrug 69 DNA intercalator 69 ZACTIMA 69 myeloproliferative diseases 69 sunitinib malate 69 PDE4 inhibitor 69 Vandetanib 69 CA4P 69 huC# DM4 69 MEK inhibitors 69 PNP inhibitor 69 dasatinib Sprycel 69 myeloproliferative disorders 69 HuMax CD4 69 DXL# 69 MAGE A3 ASCI 69 ELACYT 69 chimeric monoclonal antibody 69 Blinatumomab 69 SCCHN 69 GW# [003] 69 Angiolix 69 Panzem R 69 Janus Kinase 69 TLR9 agonist 69 Symadex 69 entinostat 69 ganetespib 69 Cytochrome P# 69 EGFR HER2 69 Phase Ib clinical 68 demonstrated antitumor activity 68 anti CD3 antibody 68 forodesine 68 rALLy clinical trial 68 Eribulin 68 NOD SCID mice 68 Bortezomib 68 Deforolimus 68 talabostat 68 anticancer compound 68 Ceflatonin 68 Bezielle 68 eniluracil 68 Orally administered 68 radiotherapeutic 68 PRT# 68 pertuzumab 68 trabectedin 68 Advanced Renal Cell 68 alkylating agent 68 phosphate S1P 68 axitinib 68 syngeneic 68 BMS# 68 proteasome inhibitors 68 IgG1 antibody 68 uricase 68 R roscovitine 68 Irinotecan 68 orally administered inhibitor 68 sorafenib tablets 68 antisense inhibitor 68 JAK inhibitors 68 humanized monoclonal 68 Neuradiab 68 metastatic malignant 68 antiproliferative effects 68 Annamycin 68 TACI Ig 68 RhuDex ® 68 trastuzumab Herceptin ® 68 liposomal formulation 68 NPC 1C 68 antitumoral 68 nucleoside analog 68 PI3K/Akt pathway inhibitor 68 TRO# 68 multikinase inhibitor 68 proteasome inhibitor bortezomib 68 mTOR inhibitor 68 acadesine 68 Afatinib 68 multicenter Phase II 68 CDK inhibitor 68 Quinamed 68 orally dosed 68 busulfan 68 alvespimycin 68 leukemia AML 68 vascular disrupting agents 68 Granulocyte Colony Stimulating Factor 68 neratinib 68 favorable pharmacokinetic profile 68 epithelial tumors 68 Tarvacin TM 68 azacytidine 68 cell lymphoma CTCL 68 AKT inhibitor 68 GMX# 68 Silodosin 68 BAY #-# 68 APOPTONE 68 Aflibercept 68 Solorel TM 68 Myocet 68 PEG SN# 68 Phase IIb clinical trials 68 CRLX# 68 immunoconjugate 68 cutaneous T 68 Hsp# Inhibitor 68 hypoxia inducible factor 68 PRTX 68 Aviptadil 68 Traficet EN 67 Panzem 67 lymphoid malignancies 67 cytoprotective 67 GAMMAGARD 67 Pralatrexate 67 luteinizing hormone releasing 67 Archexin 67 Cannabinor 67 LUX Lung 67 Trabectedin 67 therapeutic monoclonal antibody 67 immune modulatory 67 cediranib 67 OncoVEX GM CSF 67 murine model 67 antiangiogenic agent 67 IRX 2 67 immune modulating 67 HepaSphere 67 plasma kallikrein inhibitor 67 selective modulator 67 Dacogen decitabine 67 Aurora kinase 67 Safinamide 67 adult mesenchymal stem 67 cinacalcet 67 Mitoxantrone 67 CIMZIA ™ 67 vidofludimus 67 metastatic neuroendocrine tumors 67 potent anticancer 67 EpCAM 67 galiximab 67 A3 adenosine receptor 67 docetaxel Taxotere ® 67 immunotherapeutic vaccine 67 JAK1 67 potent antiproliferative 67 liposomal doxorubicin 67 flavopiridol 67 TG# [003] 67 MEK inhibitor 67 atacicept 67 systemically administered 67 cytokine refractory 67 Pathway Inhibitor 67 bevacizumab Avastin R 67 anti CD3 67 mTOR inhibition 67 multiple myeloma MM 67 phase IIb clinical 67 antifibrotic 67 CTAP# Capsules 67 lexidronam injection 67 efaproxiral 67 oral JAK1 67 Cloretazine R 67 Tarceva TM 67 ATL# [001] 67 receptor inhibitor 67 refractory chronic lymphocytic 67 JAK2 inhibitor 67 HDACi 67 personalized immunotherapy 67 gamma secretase inhibitor 67 Anticalin ® 67 Panzem NCD 67 Vicinium TM 67 EOquin TM 67 Phase 1b clinical trials 67 Phase Ib study 67 vemurafenib 67 AQ4N 67 Belerofon 67 pharmacokinetic PK study 67 KSP inhibitor 67 antitumor 67 intratumoral injection 67 cilengitide 67 familial amyloidotic polyneuropathy FAP 67 CYT# potent vascular disrupting 67 CCR9 67 HGS ETR2 67 pediatric acute lymphoblastic 67 Interferon alfa 67 FOLOTYN ® 67 PDX pralatrexate 67 Tanespimycin 67 Personalized Immunotherapy 67 LHRH receptor positive 67 adecatumumab 67 monoclonal anti 67 epigenetic therapies 67 small molecule activators 67 GLP toxicology studies 67 SSc 67 nucleotide analog 67 Guanilib 67 selective kinase inhibitor 67 mediated apoptosis 67 CD# monoclonal antibody 67 sunitinib Sutent 67 lapatinib Tykerb 67 ganaxolone 67 pegylated liposomal doxorubicin 67 Fibroblast Growth Factor Receptor 67 ALK inhibitor 67 polycythemia vera PV 67 docetaxel Taxotere R 67 enzastaurin 67 PI3K inhibitor 67 SinuNase ™ 67 Fenretinide 67 potent topoisomerase II 67 BRAF inhibitor 67 Hodgkin lymphoma HL 67 HuLuc# 67 isoform selective 67 Neulasta ® 67 humanized antibody 67 hyaluronidase enzyme 67 Tumor Necrosis Factor 67 oral antiviral 67 Annexin V 67 non nucleoside 67 antisense oligonucleotide 67 Epratuzumab 67 Ocrelizumab 67 Tarvacin 67 papillary renal cell carcinoma 67 teriflunomide 67 HDAC Inhibitor 67 EGF receptor 67 HGS# 67 ADI PEG 67 vitro cytotoxicity 67 TEMODAL 66 ISTODAX ® 66 TPI ASM8 66 Enzyme Replacement Therapy 66 Zalypsis 66 Debio 66 beta 1a 66 novel VDA molecule 66 Immunotherapeutic 66 ixabepilone 66 CCX# 66 etanercept Enbrel 66 VAPRISOL 66 mutational status 66 Epidermal Growth Factor Receptor 66 darinaparsin ZIO 66 vascular disrupting agent 66 cutaneous T cell 66 vapreotide acetate 66 effector function 66 Solazed TM 66 PCK# 66 Triapine 66 IAP inhibitor 66 kidney urologic 66 thymalfasin 66 GRN#L 66 antibody MT# 66 Ceflatonin R 66 tyrosine kinase inhibitor 66 VEGF receptor 66 Factor VEGF 66 Alocrest 66 highly selective inhibitor 66 Radiation Therapy SIRT 66 Gefitinib 66 imatinib Gleevec ® 66 NP2 66 TNFa 66 recurrent glioblastoma multiforme 66 MORAb 66 diarrhea predominant irritable 66 bleomycin 66 tocilizumab 66 huN# DM1 66 Phase Ib clinical trials 66 trastuzumab DM1 T DM1 66 HCV replicon 66 PARP inhibitor 66 anti angiogenic agent 66 murine monoclonal antibody 66 PhG alpha 1 66 Hsp# inhibition 66 OMP #R# 66 microtubule inhibitor 66 QuadraSphere 66 selective antagonist 66 IFN beta 66 interferon IFN 66 BrachySil TM 66 JAK2 inhibitors 66 EZN 66 AAG geldanamycin analog 66 hA# 66 seliciclib CYC# 66 antitumor efficacy 66 Tesmilifene 66 ara C 66 annexin V 66 MabCampath 66 MIS# 66 Prolongs Survival 66 metastatic colorectal 66 NEUMUNE 66 Fc fusion protein 66 ProMune 66 rBChE 66 Trofex 66 BRIM2 66 antiangiogenic 66 elacytarabine 66 Ozarelix 66 deforolimus 66 MAb 66 ongoing Phase 1b 66 mTOR inhibitors 66 delafloxacin 66 mediated inhibition 66 trastuzumab Herceptin 66 selective agonist 66 pathophysiological effects 66 SNT MC# 66 soluble receptor 66 CYC# 66 imatinib Gleevec 66 protein kinase inhibitor 66 antisense inhibitors 66 Bafetinib 66 generation purine nucleoside 66 OvaRex R 66 paclitaxel poliglumex 66 Talabostat 66 posaconazole 66 Inosine 66 AMN# [001] 66 ABL1 66 XmAb# 66 Nexavar sorafenib 66 Interferon alpha 66 essential thrombocythemia ET 66 ADAMTS# 66 panobinostat 66 SIR Spheres 66 Lenalidomide 66 hypereosinophilic syndrome 66 molecularly targeted 66 Marqibo TM 66 Atrasentan 66 thetreatment 66 5 Fluorouracil 66 goserelin 66 OvaRex ® MAb 66 sipuleucel T 66 solithromycin 66 intravesical instillation 66 Vascugel ® 66 concurrent chemoradiation 66 anti amnesic 66 dose escalation Phase 66 PrevOnco ™ 66 #I TM# 66 nilotinib Tasigna 66 Everolimus 66 Dapagliflozin 66 peptidomimetic 66 platelet inhibitor 66 dasatinib Sprycel ® 66 humanised antibody 66 Lenocta 66 Velcade bortezomib 66 SYN# 66 pomalidomide 66 Triapine R 66 RAV# 66 Thiarabine 66 kallikrein 66 lenalidomide Revlimid R 66 p# inhibitor 66 pharmacodynamic properties 66 Cutaneous T 66 ESBA# 66 alefacept 66 TÎ ² 4 66 ATL/TV# 66 monoclonal antibody conjugated 66 CANCIDAS 66 Hepatocellular Carcinoma HCC 66 accumulate preferentially 66 OHR/AVR# 66 intranasal formulation 66 TLK# 66 sodium glucose cotransporter 66 gastrointestinal stromal tumors GIST 66 BCIRG 66 ISF# 66 adalimumab Humira 66 relapsing multiple sclerosis 66 interleukin IL 66 novel prodrug 66 bevacizumab Avastin 66 Genasense ® 66 prostate cancer AIPC 66 non nucleoside HCV 66 Clolar ® 66 Androxal TM 66 topoisomerase II inhibitor 66 EGFr 66 PEGylated anti 66 PEGylated interferon beta 1a 66 Fludara ® 66 benzimidazole 66 myelodysplastic myeloproliferative diseases 66 anticancer activity 65 PSN# [002] 65 phase IIa clinical 65 Ontak 65 oncolytic virus therapy 65 Luteinizing Hormone Releasing Hormone 65 denileukin diftitox 65 humanized monoclonal antibody 65 efalizumab 65 antitumor activity 65 CCR2 65 Protelos R 65 HGS ETR1 65 recurrent NSCLC 65 LB# [003] 65 cleavable linker 65 immune modulator 65 Sudhir Agrawal D.Phil 65 Denufosol 65 imetelstat 65 Zybrestat 65 JAK3 65 riociguat 65 micafungin 65 irreversible inhibitor 65 evaluating tivozanib 65 pharmacokinetic PK 65 adecatumumab MT# 65 metastatic RCC 65 Akt activation 65 Campath ® 65 EndoTAG TM -1 65 tranilast 65 Enzastaurin 65 Virulizin ® 65 ISTODAX 65 Exherin TM 65 HepDirect prodrug 65 bispecific antibody 65 compound AEZS 65 IMC A# 65 Nilotinib 65 Vitaxin 65 oral ridaforolimus 65 TLR9 agonists 65 Taxotere chemotherapy 65 oxazolidinone 65 vitro experiments 65 castrate resistant prostate cancer 65 protein tyrosine phosphatase 65 sulodexide 65 SCH # 65 triphendiol 65 Janus kinase 65 Leukine ® 65 non nucleoside inhibitor 65 Romiplostim 65 PI3K Akt 65 Mucosal 65 metastatic gastric 65 telomerase inhibitor 65 cMET 65 decitabine 65 IgG1 monoclonal antibody 65 Alfacell proprietary ribonuclease 65 MET VEGFR2 65 HIF 1α 65 Lubiprostone 65 velafermin 65 erlotinib Tarceva 65 Thrombin 65 peptide conjugated 65 JAK inhibitor 65 ERK1 2 65 vesicular monoamine transporter 65 sodium thiosulfate STS 65 Ampligen ® 65 ProLindac TM 65 EndoTAG TM 65 Chemokine Receptor 65 tafamidis 65 myelofibrosis polycythemia vera 65 anti fibrotic 65 novel anticancer 65 histamine dihydrochloride 65 immune modulation 65 bendamustine 65 immunomodulator 65 relapsed ovarian cancer 65 potently inhibited 65 vinorelbine tartrate 65 XYOTAX TM 65 mouse xenograft models 65 BCR ABL inhibitor 65 PEGylated interferon 65 Tyrosine Kinase Inhibitor 65 acetonide FA 65 biodistribution 65 pro angiogenic 65 humanized monoclonal antibodies 65 thymosin beta 4 65 pharmacodynamic PD 65 verteporfin 65 Daclizumab 65 Parathyroid Hormone 65 Doxil ® 65 Chronic Lymphocytic Leukemia CLL 65 rxRNA 65 chemoradiotherapy 65 induces apoptosis 65 drug conjugate 65 assessing T DM1 65 BLP# Liposome Vaccine 65 ZYBRESTAT fosbretabulin 65 antiproliferative activity 65 radiolabeled TM# 65 RNAi therapeutic targeting 65 cartilage regeneration 65 Estrogen Receptor 65 Preclinical studies suggest 65 Cytotoxic 65 HDL Selective Delipidation 65 tipifarnib 65 prucalopride 65 hormone agonist 65 gemcitabine Gemzar ® 65 multi kinase inhibitor 65 Civacir 65 Elvitegravir 65 ZK EPO 65 p# biomarker 65 docetaxel Taxotere 65 SERMs 65 Voreloxin 65 hormone LHRH antagonist 65 Clusterin 65 brostallicin 65 relapsed leukemia 65 MyVax R 65 investigational monoclonal antibody 65 ToGA 65 AVI NEUGENE 65 oncolytic virus 65 Initiates Clinical 65 Gleevec imatinib mesylate 65 Fx #A 65 Natalizumab 65 varespladib 65 metaglidasen 65 androgen receptor AR 65 elotuzumab 65 neoadjuvant treatment 65 metastatic renal cell carcinoma 65 rhMBL 65 small molecule Hedgehog 65 immunoregulatory 65 PC# cells 65 immunomodulatory 65 rituximab Rituxan 65 Angiotensin Converting Enzyme 65 telomerase therapeutic 65 cathepsin K inhibitor 65 radezolid 65 gastrointestinal stromal tumors GISTs 65 radiolabeled 65 MVA MUC1 IL2 65 subcutaneous SC 65 Temsirolimus 65 siRNAs targeting 65 gastric adenocarcinoma 65 sunitinib Sutent ® 65 fibrotic disease 65 Tamibarotene 65 prostate carcinoma 65 fallopian tube cancers 65 MTP inhibitor 65 EndoTAGTM 1 65 monoclonal antibody mAb 65 phase IIb trial 65 immunotoxins 65 PORxin TM 65 estramustine 65 relapsed MM 65 ONCASPAR 65 brivaracetam 65 ADP receptor antagonist 65 naturally occurring molecule 65 VitiGam 65 IFN β 65 CD3 monoclonal antibody 65 paclitaxel Taxol 65 ALN TTR# 65 CR# vcMMAE 65 immunomodulatory therapy 65 Myelodysplastic Syndrome MDS 65 multicenter phase 65 chemotherapeutic drug 65 Amplimexon 65 Pyridorin TM 65 Eculizumab 65 PROSTVAC VF 65 RH1 65 paclitaxel Taxol ® 65 small molecule activator 65 drug zotarolimus 65 Tezampanel 65 chemotherapeutic agent 65 LY# [003] 65 vismodegib 65 IGF IR 65 Pazopanib 65 Aclidinium 65 SAR# [004] 65 Liposomal 65 Vascular Wrap TM 65 potent cytotoxic 65 phase Ib 65 mu opioid receptor antagonist 65 KNS # 65 superficial bladder cancer 65 fluoropyrimidine 65 UPLYSO 65 Protexia ® 65 Curaxin CBLC# 65 pharmacological chaperone 65 novel oral anticoagulant 65 trastuzumab emtansine T DM1 65 Clofarabine 65 partial agonist 65 selective adenosine 65 Vorinostat 65 gemcitabine cisplatin 65 TKB# 65 perifosine KRX 65 hepatocellular carcinoma HCC 65 tanespimycin 65 Phase 2a trial 65 tolerability pharmacokinetics 65 sargramostim 65 factor Xa inhibitor 65 dexpramipexole 65 VNP#M 65 delta isoform 65 GLYX 65 Monoclonal antibody 65 AEGR 65 HIF PHI 65 ThermoDox R 65 hematologic malignancies 65 HER2 ErbB2 65 cysteamine bitartrate 65 PEP# [003] 65 Phase 1a clinical 65 P#X# 65 Antiangiogenic 65 ErbB2 positive 65 #F FDG PET 65 oncolytic vaccine 65 INCB# [003] 65 Perifosine 65 nicotinic alpha 7 65 immunomodulating 65 CLL SLL 65 apoptotic pathway 65 proto oncogene 65 zanolimumab 65 Antiviral Activity 65 LEUKINE 65 CCR1 65 Apaziquone 65 CB2 selective receptor agonist 65 PD LID 65 microsphere therapy 65 peripheral blood mononuclear 64 INSPIRE Trial Phase III 64 PGL# 64 Phase III randomized controlled 64 meropenem 64 Trastuzumab 64 Zorbtive TM 64 poly ADP ribose polymerase 64 Kamada AAT 64 Trandolapril 64 Kinase Inhibitor 64 taxane resistant 64 pancreatic adenocarcinoma 64 DAVANAT 64 mycophenolate mofetil 64 factor G CSF 64 IFN α 64 estrogen receptor antagonist 64 haematological cancers 64 chronic eosinophilic leukemia 64 HCV protease inhibitors 64 Pentraxin 2 64 GAP #B# 64 VEGF inhibitors 64 androgen independent 64 hormone LHRH 64 vivo validation 64 Campath alemtuzumab 64 retinoic acid receptor 64 Calcitonin 64 5 HT4 receptor 64 LymphoStat B TM 64 MT# MEDI 64 antiapoptotic 64 IAP inhibitors 64 HCV SPRINT 64 erythropoietic 64 refractory cutaneous T 64 mGluR2 NAM 64 EXPAREL TM 64 Neulasta R 64 Solesta 64 proteoglycan 64 tubulin binding 64 Metastatic Melanoma 64 Tesetaxel 64 PDGF receptor 64 NXL# 64 Telintra 64 histone deacetylase inhibitors 64 demethylating agent 64 gemcitabine Gemzar 64 ATIR 64 prostate cancer mCRPC 64 epothilones 64 Phase IIB 64 Muraglitazar 64 Onalta TM 64 DermaVir Patch 64 paricalcitol 64 RNA antagonist 64 BiTE antibody 64 Curaxin 64 ocular formulation 64 Interferon Beta 64 seliciclib 64 brivanib 64 selectively inhibits 64 anti angiogenic therapy 64 serine protease 64 pharmacodynamic markers 64 Radilex 64 hypoxia activated prodrug 64 Anticalins ® 64 Hedgehog Pathway Inhibitor 64 ONCONASE 64 antitumor effects 64 Pyridorin 64 Tocilizumab 64 milatuzumab 64 castration resistant prostate cancer 64 basal cell carcinoma BCC 64 pDC 64 PEG IFN 64 immunotoxin 64 phase IIIb 64 GAMMAGARD LIQUID 64 PrevOnco 64 microtubule targeting 64 TGF beta1 64 NEUVENGE 64 IL 1ß 64 colorectal liver metastases 64 protein tyrosine phosphatase 1B 64 somatostatin analog 64 biodistribution studies 64 annexin 64 HCV protease 64 Preclinical studies 64 Presents Preclinical Data 64 Lp PLA 2 64 chemokine receptor 64 IGF 1R inhibitor 64 benign prostatic hypertrophy BPH 64 ulimorelin 64 mecamylamine 64 tumor xenograft models 64 CD# expressing 64 Vectibix panitumumab 64 TNF α 64 Hepatocellular Carcinoma 64 Xyfid TM 64 Allovectin 7 ® 64 Upregulation 64 anti EGFR antibody 64 beta interferons 64 novel immunotherapeutic 64 reversible inhibitor 64 Glypromate 64 modulator SERM 64 OncoVex 64 cervical carcinoma 64 ritonavir boosted 64 Modrenal 64 direct thrombin inhibitors 64 sitaxsentan 64 Glufosfamide 64 QUADRAMET R 64 malignant pleural mesothelioma 64 small molecule tyrosine 64 peptide antigens 64 Onalta 64 Vascugel R 64 PI3K/mTOR 64 humanised monoclonal antibody 64 Factor Xa inhibitor 64 DOS# 64 Plicera 64 PARP inhibition 64 Pimavanserin 64 monoclonal 64 Valortim R 64 kinase inhibition 64 IMP# 64 immune stimulatory 64 ZD# [001] 64 investigational therapies 64 EGFR expressing 64 antineoplastic 64 NEUGENE 64 EXPAREL ™ 64 PEGPH# 64 hematological cancers 64 Teplizumab 64 Elesclomol 64 cell adhesion molecule 64 immatics 64 Neoadjuvant 64 cetuximab Erbitux ® 64 vivo efficacy 64 small molecule modulators 64 LHRH agonists 64 midstage clinical 64 alagebrium 64 adipogenic 64 2 methoxyestradiol 64 ACZ# 64 Saforis 64 farletuzumab 64 5alpha reductase 64 camptothecin 64 eprotirome 64 samarium Sm 64 Erbitux cetuximab 64 neuroprotective properties 64 investigational immunotherapy 64 relapsed refractory multiple myeloma 64 demethylating agents 64 BGC# 64 CaPre TM 64 BAL# [001] 64 Ataluren 64 selective inhibitor 64 2 inhibitor CYT# 64 kinase inhibitor 64 DU #b 64 TRAIL receptor 64 HER2 antibody 64 vWF 64 glufosfamide 64 tolerability profiles 64 Insegia 64 antisense drug 64 GRN# 64 IL #E 64 Rituxan rituximab 64 Corgentin 64 OPAXIO 64 IMiDs R 64 sphingosine kinase 64 Acute Radiation Syndrome ARS